To facilitate the move, MediVera™ will be closed on Friday, March 21, 2025. Normal business hours will resume at the new facility on Monday, March 24.
The new 56,000-square-foot facility is
designed to enhance MediVera's commitment to quality and innovation in
compounding pharmacy services. We welcome the public to celebrate with us at
our grand opening event on May 1, 2025,
from 11:00 AM to 1:00 PM at our new location. Guests will have the
opportunity to tour the facility and meet our team. The new building is
equipped with advanced ISO-7 cleanrooms and ISO-5 hoods. These features ensure
compliance with USP 795, 797, and 800 regulations. These state-of-the-art
sterile and non-sterile compounding suites are designed to meet stringent
regulatory standards for the preparation of both hazardous and non-hazardous
compounds, in accordance with USP 795, 797, and 800 guidelines.
"The opening of this facility represents a significant milestone for MediVera™, our employees, and the healthcare providers we serve," said Bradley McCloskey, PharmD, CEO of MediVera Compounding Pharmacy™. "This
investment in cutting-edge technology and compliance ensures that we continue
to provide the highest level of quality and service in the industry. We remain
committed to exceeding expectations in personalized medicine and patient
care."
MediVera™ employs a dedicated team of 120 professionals, including nine compounding pharmacists, all focused on delivering personalized care. The company invests $30,000 monthly in third-party testing to ensure all formulations meet and exceed standards for potency and sterility. MediVera Compounding Pharmacy™ is PCAB-accredited in both sterile and non-sterile pharmacy compounding—a distinction held by fewer than 1% of pharmacies. The American Medical Association (AMA) recommends physicians only use PCAB-accredited compounding pharmacies.
Licensed to operate in and ship to 43 states, MediVera™ continues to expand its reach, bringing personalized medicine to patients nationwide. Our proprietary customer service program, The Impressed Advantage by MediVera Compounding Pharmacy™, delivers fast shipping, dedicated account management, and ongoing education for providers while also enhancing patient support. We simplify prescription fulfillment so patients can focus on their health—contacting each patient within one business day, answering most calls within 30 seconds, and shipping most compounds within 48 hours of confirmation. The new facility in Troy represents a major step forward in our mission to provide exceptional, customized pharmaceutical care.
43 States: AK, AZ, CO, CT, DE, FL, GA,
ID, IL, IA, IN, KS, KY, LA, ME, MD, MA, MI, MN, MO, MT, NE, NH, NJ, NM, NY, NC,
ND, OH, OK, OR, PA, RI, SC, SD, TN, UT, VA, VT, WA, WV, WI, WY.
About MediVera Compounding Pharmacy™
Founded in 1999, MediVera Compounding Pharmacy™ has been at the forefront of personalized medicine, offering tailored pharmaceutical solutions to meet the unique needs of healthcare providers and patients. With a focus on quality, safety, and customer satisfaction, MediVera™ continues to set industry standards in compounding pharmacy services.
Media Contact:
Laurie Malseed
Marketing Manager
MediVera Compounding Pharmacy™
laurie@mediverarx.com
mediverarx.com
# # #